CELU vs GPCR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GPCR Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Structure Therapeutics Inc. American Depositary Shares (GPCR) driven by superior Growth & Margin, Options & Structure while CELU counters with relative strength in Momentum & Technical. Fundamentally, CELU trades at N/M Forward P/E with -254.0% operating margin (-5.3% YoY revenue) versus GPCR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against GPCR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CELU | GPCR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.2M | $1.2B | Larger Scale | GPCR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -5.3% | +0.0% | Higher Growth | GPCR |
| Operating Margin (TTM) Profitability | -254.0% | 0.0% | Higher Margin | GPCR |
| Net Profit Margin Profitability | -245.7% | 0.0% | Higher Margin | GPCR |
| Return on Equity (ROE) Capital Efficiency | -6367.2% | -29.5% | Higher ROE | GPCR |
| 52-Week Range Position Momentum | 2% ($0โ$3) | 0% ($16โ$95) | Stronger Trend | CELU |
| Beta / 30D Volatility Risk Regime | 2.01ฮฒ ยท 135% Vol | 1.31ฮฒ ยท 58% Vol | Lower Realized Risk | GPCR |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 40.9 / 100 (SELL) | Higher Composite | CELU |